Volume 9 - Special Issue of Intellectual Property Law                   MLJ 2016, 9 - Special Issue of Intellectual Property Law: 125-150 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khavaninzadeh M H, Erfanmanesh M H. Examination on Development of Patenting DNA Inventions with Emphasis on US Supreme Court on Association for Molecular Pathology v. Myriad Genetics. MLJ. 2016; 9 :125-150
URL: http://ijmedicallaw.ir/article-1-673-en.html
1- دانشکده الهیات و معارف اسلامی، دانشگاه علامه طباطبایی، تهران، ایران
2- دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران

Patentability of inventions related to biotechnology and genetics has been one of the most challenging issues in patent law. One of these challenges is whether patenting products in which natural components are used is correct? Can we put human genes in the ownership of certain individuals? In addition, exercising exclusive rights arising from patents will limit the access of people, in particular, patients, doctors and researchers to the subject of patents. The decision of the US Supreme Court in Association for Molecular Pathology v. Myriad Genetics has put an end to many controversies and debates about isolated DNA sequences. The Supreme Court held that merely isolating genes that are found in nature does not render the invention patentable. Analyzing this decision, this article examines the patentability of DNA in Europe and USA.

Type of Study: Original Article |
Received: 2015/04/19 | Accepted: 2015/09/19

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Medical Law Journal

Designed & Developed by : Yektaweb